Education
Dr. Med. in Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
Current position
Resident, Pediatric Hematology and Oncology, Hannover Medical School, Hannover (2014-present)
Emmy Noether Junior Research Group leader of “Pediatric Hematology and Oncology”, Hannover Medical School (2011-present)
Publications
-
Stankov, M. V., El Khatib, M., Kumar Thakur, B., Heitmann, K., Panayotova-Dimitrova, D., Schoening, J., Bourquin, J. P., Schweitzer, N., Leverkus, M., Welte, K., Reinhardt, D., Li, Z., Orkin, S. H., Behrens, G. M. and Klusmann, J. H. (2014). Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 28(3): 577-588.
-
Maroz, A., Stachorski, L., Emmrich, S., Reinhardt, K., Xu, J., Shao, Z., Kabler, S., Dertmann, T., Hitzler, J., Roberts, I., Vyas, P., Juban, G., Hennig, C., Hansen, G., Li, Z., Orkin, S., Reinhardt, D. and Klusmann, J. H. (2013). GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia. Leukemia. [Epub ahead of print]
-
Emmrich, S.*, Katsman-Kuipers, J. E.*, Henke, K., Khatib, M. E., Jammal, R., Engeland, F., Dasci, F., Zwaan, C. M., den Boer, M. L., Verboon, L., Stary, J., Baruchel, A., de Haas, V., Danen-van Oorschot, A. A., Fornerod, M., Pieters, R., Reinhardt, D., Klusmann, J. H.* and van den Heuvel-Eibrink, M. M.* (2013). miR-9 is a tumor suppressor in pediatric AML with t(8;21). Leukemia. [Epub ahead of print] *Contributed equally
-
Gross, B., Sgodda, M., Rasche, M., Schambach, A., Gohring, G., Schlegelberger, B., Greber, B., Linden, T., Reinhardt, D., Cantz, T. and Klusmann, J. H. (2013). Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach. Curr Mol Med 13(5): 765-776.
-
Emmrich, S., Henke, K., Hegermann, J., Ochs, M., Reinhardt, D. and Klusmann, J. H. (2012). miRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol 91(11): 1673-1684.
-
Klusmann, J. H., Reinhardt, D., Zimmermann, M., Kremens, B., Vormoor, J., Dworzak, M., Creutzig, U. and Klingebiel, T. (2012). The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica 97(1): 21-29.
-
Klusmann, J. H., Godinho, F. J., Heitmann, K., Maroz, A., Koch, M. L., Reinhardt, D., Orkin, S. H. and Li, Z. (2010). Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 24(15): 1659-1672.
-
Klusmann, J. H., Li, Z., Bohmer, K., Maroz, A., Koch, M. L., Emmrich, S., Godinho, F. J., Orkin, S. H. and Reinhardt, D. (2010). miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev 24(5): 478-490.
-
Klusmann, J. H., Creutzig, U., Zimmermann, M., Dworzak, M., Jorch, N., Langebrake, C., Pekrun, A., Macakova-Reinhardt, K. and Reinhardt, D. (2008). Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 111(6): 2991-2998.
-
Klusmann, J. H., Reinhardt, D., Hasle, H., Kaspers, G. J., Creutzig, U., Hahlen, K., van den Heuvel-Eibrink, M. M. and Zwaan, C. M. (2007). Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome. Leukemia 21(7): 1584-1587.
-
Li, Z., Godinho, F. J., Klusmann, J. H., Garriga-Canut, M., Yu, C. and Orkin, S. H. (2005). Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet 37(6): 613-619.